Table 3 |
||
|
Repeated Measures Testing |
||
|
Effect of Time |
Effect of Treatment on Time |
|
|
|
||
|
PDSS |
||
|
All Subjects |
F (9,40) = 3.71; p = 0.002 |
F (9, 40) = 1.11; p = 0.10 |
|
Low Ham-D group1 |
F (9,14) = 2.69; p = 0.047 |
F (9,14) = 2.01; p = 0.12 |
|
High Ham-D group2 |
F (9,16) = 1.98; p = 0.11 |
F (9,16) = 0.22; p = 0.99 |
|
|
||
|
PDSS q1 |
||
|
All Subjects |
F (8,44) = 4.42; p < 0.001 |
F (8,44) = 1.41; p = 0.22 |
|
Low Ham-D group1 |
F (8,17) = 2.34; p < 0.067 |
F (8,17) = 1.85; p = 0.14 |
|
High Ham-D group2 |
F (8,18) = 1.75; p = 0.15 |
F (8,18) = 0.45; p = 0.87 |
|
|
||
|
PDSS q2 |
||
|
All Subjects |
F (8,44) = 5.16; p < 0.001 |
F (8,44) = 1.25; p = 0.29 |
|
Low Ham-D group1 |
F (8,18) = 5.19; p < 0.002 |
F (8,18) = 0.85; p = 0.57 |
|
High Ham-D group2 |
F (9,18) = 2.3; p = 0.064 |
F (9,18) = 1.36; p = 0.28 |
|
|
||
|
Ham-A |
||
|
All Subjects |
F (8,43) = 8.81; p < 0.001 |
F (8,43) = 1.90; p = 0.077 |
|
Low Ham-D group1 |
F (9,15) = 4.24; p = 0.007 |
F (9,15) = 1.96; p = 0.12 |
|
High Ham-D group2 |
F (9,18) = 5.05; p = 0.002 |
F (9,18) = 0.75; p = 0.66 |
|
|
||
|
SPAS-p |
||
|
All Subjects |
F (9,41) = 0.80; p = 0.62 |
F (9,41) = 0.57; p = 0.82 |
|
|
||
|
Ham-D |
||
|
All Subjects |
F (9,43) = 4.30; p < 0.001 |
F (9,43) = 1.17; p = 0.33 |
|
|
||
|
Outcome measures tested by a General Linear Model Repeated Measures analysis. Testing was initially done for all subjects together, and then for subjects grouped into high or low Ham-D groups based on initial Ham-D scores. 1 – Subset of patients with Ham-D scores < 27 2 – Subset of patients with Ham-D scores ≥ 27 |
||
|
Prosser et al. BMC Psychiatry 2009 9:25 doi:10.1186/1471-244X-9-25 |
||
